OBJECTIVES: Successful surgical management of thoracic aortic aneurysms (TAA) and thoracoabdominal aortic aneurysms (TAAA) has historically relied upon open surgical repair (OSR). More recently, the advent and application of thoracic endovascular stent graft aneurysm repair (TEVAR) permutations have become increasingly performed in contemporary practice. To better determine the effect of TEVAR techniques on OSR, we examined national and regional trends in treatment use. METHODS: All Medicare patients from 1998 through 2007 undergoing isolated TAA and TAAA repair were analyzed using a clinically validated algorithm using diagnostic International Classification of Disease 9th revision (ICD-9; 441.1, 441.2, 441.6, 441.7, 441.9) codes and procedural (ICD-9 OSR: 38.35, 38.45 and TEVAR: 39.73, 39.79) codes. Differential rates of OSR and TEVAR were compared across census tract regions during the study interval. RESULTS: Total complex aortic repairs increased by 60%, from 10.8 to 17.8/100,000, between 1998 and 2007 (P < .001). A dramatic increase occurred in TEVAR (not performed in 1998, 5.8/100,000 in 2007) during the study period, but OSR rates remained stable during the same interval (10.7 to 12.0/100,000 in 2007, P = NS). There was substantial regional variation for both OSR and TEVAR. This regional variation was greater in OSR (range, 8.8-16.7/100,000) than in TEVAR (range, 4.5-6.9/100,000). CONCLUSIONS: Degenerative TAA and TAAA aneurysms are being repaired in the United States at an increasing rate. This reflects the rapid acceptance of TEVAR, which apparently supplements rather than supplants OSR. There appears to be greater regional variation in OSR compared with TEVAR. These data may have significant implications for those interested in the effect of new technologies on health care and cost containment.
OBJECTIVES: Successful surgical management of thoracic aortic aneurysms (TAA) and thoracoabdominal aortic aneurysms (TAAA) has historically relied upon open surgical repair (OSR). More recently, the advent and application of thoracic endovascular stent graft aneurysm repair (TEVAR) permutations have become increasingly performed in contemporary practice. To better determine the effect of TEVAR techniques on OSR, we examined national and regional trends in treatment use. METHODS: All Medicare patients from 1998 through 2007 undergoing isolated TAA and TAAA repair were analyzed using a clinically validated algorithm using diagnostic International Classification of Disease 9th revision (ICD-9; 441.1, 441.2, 441.6, 441.7, 441.9) codes and procedural (ICD-9 OSR: 38.35, 38.45 and TEVAR: 39.73, 39.79) codes. Differential rates of OSR and TEVAR were compared across census tract regions during the study interval. RESULTS: Total complex aortic repairs increased by 60%, from 10.8 to 17.8/100,000, between 1998 and 2007 (P < .001). A dramatic increase occurred in TEVAR (not performed in 1998, 5.8/100,000 in 2007) during the study period, but OSR rates remained stable during the same interval (10.7 to 12.0/100,000 in 2007, P = NS). There was substantial regional variation for both OSR and TEVAR. This regional variation was greater in OSR (range, 8.8-16.7/100,000) than in TEVAR (range, 4.5-6.9/100,000). CONCLUSIONS: Degenerative TAA and TAAA aneurysms are being repaired in the United States at an increasing rate. This reflects the rapid acceptance of TEVAR, which apparently supplements rather than supplants OSR. There appears to be greater regional variation in OSR compared with TEVAR. These data may have significant implications for those interested in the effect of new technologies on health care and cost containment.
Authors: Joseph E Bavaria; Jehangir J Appoo; Michel S Makaroun; Joel Verter; Zi-Fan Yu; R Scott Mitchell Journal: J Thorac Cardiovasc Surg Date: 2007-01-08 Impact factor: 5.209
Authors: Ronald M Fairman; Frank Criado; Mark Farber; Christopher Kwolek; Manish Mehta; Rodney White; Anthony Lee; J Michael Tuchek Journal: J Vasc Surg Date: 2008-06-24 Impact factor: 4.268
Authors: L K Bickerstaff; P C Pairolero; L H Hollier; L J Melton; H J Van Peenen; K J Cherry; J W Joyce; J T Lie Journal: Surgery Date: 1982-12 Impact factor: 3.982
Authors: Robert S Crawford; Juan D Pedraza; Thomas K Chung; Michael Corey; Mark F Conrad; Richard P Cambria Journal: J Vasc Surg Date: 2008-07-26 Impact factor: 4.268
Authors: Jon S Matsumura; Richard P Cambria; Michael D Dake; Randy D Moore; Lars G Svensson; Scott Snyder Journal: J Vasc Surg Date: 2008-02 Impact factor: 4.268
Authors: Lars G Svensson; Nicholas T Kouchoukos; D Craig Miller; Joseph E Bavaria; Joseph S Coselli; Michael A Curi; Holger Eggebrecht; John A Elefteriades; Raimund Erbel; Thomas G Gleason; Bruce W Lytle; R Scott Mitchell; Christoph A Nienaber; Eric E Roselli; Hazim J Safi; Richard J Shemin; Gregorio A Sicard; Thoralf M Sundt; Wilson Y Szeto; Grayson H Wheatley Journal: Ann Thorac Surg Date: 2008-01 Impact factor: 4.330
Authors: Nathan L Liang; Theodore H Yuo; Georges E Al-Khoury; Eric S Hager; Michel S Makaroun; Michael J Singh Journal: J Vasc Surg Date: 2017-04-08 Impact factor: 4.268
Authors: Paul C Tang; Paul D DiMusto; Nilto C De Oliveira; Brooks L Rademacher; Jennifer L Philip; Shahab A Akhter; Charles W Acher Journal: J Vasc Surg Date: 2017-12-21 Impact factor: 4.268
Authors: Joseph S Coselli; Konstantinos Spiliotopoulos; Ourania Preventza; Kim I de la Cruz; Hiruni Amarasekara; Susan Y Green Journal: Gen Thorac Cardiovasc Surg Date: 2016-06-17
Authors: Philip P Goodney; Lori Travis; F Lee Lucas; Mark F Fillinger; David C Goodman; Jack L Cronenwett; David H Stone Journal: Circulation Date: 2011-11-21 Impact factor: 29.690
Authors: Asad A Shah; Michael E Barfield; Nicholas D Andersen; Judson B Williams; Julie A Shah; Jennifer M Hanna; Richard L McCann; G Chad Hughes Journal: Ann Thorac Surg Date: 2012-07-10 Impact factor: 4.330
Authors: Douglas W Jones; Philip P Goodney; Brian W Nolan; Benjamin S Brooke; Mark F Fillinger; Richard J Powell; David H Stone Journal: J Vasc Surg Date: 2014-02-28 Impact factor: 4.268
Authors: Salvatore T Scali; Catherine K Chang; Robert J Feezor; Philip J Hess; Thomas M Beaver; Tomas D Martin; Thomas S Huber; Adam W Beck Journal: J Vasc Surg Date: 2012-07-25 Impact factor: 4.268
Authors: Salvatore T Scali; Adam W Beck; Khayree Butler; Robert J Feezor; Tomas D Martin; Philip J Hess; Thomas S Huber; Catherine K Chang Journal: J Vasc Surg Date: 2014-03 Impact factor: 4.268
Authors: Salvatore T Scali; S Keisin Wang; Robert J Feezor; Thomas S Huber; Tomas D Martin; Charles T Klodell; Thomas M Beaver; Adam W Beck Journal: J Vasc Surg Date: 2014-10-03 Impact factor: 4.268